A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients
Simeon Metallidis, Panagiotis Kollaras, Theodoros Giannakakis, Basilis Seitanidis, Theodoros Kordosis, John Nikolaidis, Apostolos Hatzitolios, Pavlos NikolaidisVolume:
19
Year:
2008
Language:
english
Pages:
625
DOI:
10.1016/j.ejim.2007.08.011
File:
PDF, 149 KB
english, 2008